News
The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...
Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...
The breakthrough double injection won’t be cheap in the US, although scientists argue it could (and should) be.
FRIDAY, June 20, 2025 (HealthDay News) — A new shot to prevent HIV infection has just been approved — and it only needs to be taken twice a year. On Wednesday, the U.S. Food and Drug Administration ...
A United Nations agency has urged the pharmaceutical company Gilead Sciences to lower the price of the long acting antiviral treatment lenacapavir following the US Food and Drug Administration (FDA)’s ...
Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...
The Wistar Institute has launched its HIV Cure and Viral Diseases Center with new lab space on Market Street and a plan to ...
20h
Health and Me on MSNFDA Approves HIV Shot That’s 99.9% Effective; Is This The Beginning Of The End For The Viral Epidemic?The FDA approved Yeztugo (lenacapavir), a twice-yearly injection that prevents HIV with up to 99.9% effectiveness, showing ...
Greek City Times Scientists Delete HIV from Human Cells in World-First Breakthrough Scientists have successfully deleted the ...
June 19, 2025 – The FDA has approved the first twice-yearly shot to reduce the risk of HIV infections.
The U.S. Food and Drug Administration (FDA) approved a new, twice-yearly shot — the first and only of its kind — to prevent ...
The 2025 Warren Alpert Foundation Prize has been awarded to three scientists whose discoveries culminated in the development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results